Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses

Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses

Abstract Background Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare pulmonary disease caused by functional deficiency of granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-CSF therapy in aPAP has been reported effective in some studies. This meta-analyses aimed to evaluate whet...

Full description

Bibliographic Details
Main Authors: Gaohong Sheng, Peng Chen, Yanqiu Wei, Jiaojiao Chu, Xiaolei Cao, Hui-Lan Zhang
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Respiratory Research
Subjects:
Autoimmune pulmonary alveolar proteinosis
Granulocyte-macrophage colony-stimulating factor
Inhaled GM-CSF
Subcutaneous GM-CSF
Meta-analyses
Online Access:http://link.springer.com/article/10.1186/s12931-018-0862-4

Internet

http://link.springer.com/article/10.1186/s12931-018-0862-4

Similar Items